Takaaki Fujii Selected Research

Takaaki Fujii Research Topics

Disease

43	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2012
39	Neoplasms (Cancer) 01/2022 - 05/2011
12	Colorectal Neoplasms (Colorectal Cancer) 07/2016 - 09/2011
10	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2010
7	Ischemia 04/2010 - 01/2006
6	Lymphatic Metastasis 06/2016 - 01/2012
5	Triple Negative Breast Neoplasms 03/2020 - 12/2017
5	Colonic Neoplasms (Colon Cancer) 11/2019 - 08/2011
3	Infections 07/2019 - 05/2011
3	Inflammation (Inflammations) 08/2018 - 07/2014
3	Rectal Neoplasms (Rectal Cancer) 05/2015 - 11/2011
2	Obesity 07/2020 - 01/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2017 - 01/2017
2	Ileus 03/2015 - 08/2011
2	Hyperthermia 06/2014 - 11/2011
2	Primary Hyperparathyroidism 04/2012 - 06/2011
2	Peptic Ulcer (Peptic Ulcers) 07/2009 - 05/2009
2	Diabetic Angiopathies (Diabetic Angiopathy) 06/2008 - 01/2006
2	Diabetic Foot 06/2008 - 01/2006
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Alopecia (Baldness) 03/2021
1	Lobular Carcinoma 11/2020
1	Disease Progression 03/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Contracture 07/2019
1	Congenital Abnormalities (Deformity) 07/2019

Drug/Important Bio-Agent (IBA)

9	Estrogen ReceptorsIBA 12/2021 - 06/2016
9	Proteins (Proteins, Gene)FDA Link 04/2020 - 04/2010
8	Indicators and Reagents (Reagents)IBA 08/2018 - 01/2014
7	Biological ProductsIBA 03/2019 - 07/2011
6	Messenger RNA (mRNA)IBA 11/2020 - 04/2010
6	Biomarkers (Surrogate Marker)IBA 09/2020 - 04/2006
5	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2018
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 03/2015
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 06/2016
5	C-Reactive ProteinIBA 08/2018 - 05/2011
4	Serum AlbuminIBA 07/2020 - 09/2011
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2009 - 04/2006
3	human ERBB2 proteinIBA 01/2022 - 01/2018
3	Phenobarbital (Luminal)FDA Link 01/2022 - 03/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2021 - 11/2020
3	Fluorouracil (Carac)FDA LinkGeneric 03/2021 - 11/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 09/2008
3	AlbuminsIBA 07/2020 - 01/2012
3	Becaplermin (PDGF-BB)FDA Link 11/2009 - 01/2006
3	Therapeutic UsesIBA 09/2008 - 04/2006
2	130-nm albumin-bound paclitaxelIBA 08/2021 - 04/2020
2	neratinibIBA 11/2020 - 01/2020
2	LigandsIBA 09/2020 - 12/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2018
2	Androgen Receptors (Androgen Receptor)IBA 07/2019 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2018 - 02/2013
2	Pharmaceutical PreparationsIBA 03/2016 - 06/2012
2	Prealbumin (Transthyretin)IBA 07/2014 - 01/2012
2	Bevacizumab (Avastin)FDA Link 05/2014 - 06/2012
2	Vascular Endothelial Growth Factor CIBA 03/2013 - 11/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2009 - 06/2008
2	Streptozocin (Streptozotocin)FDA Link 06/2008 - 01/2006
1	Large Neutral Amino Acid-Transporter 1IBA 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	Acetates (Acetic Acid Esters)FDA Link 05/2021
1	Tamoxifen FDA LinkGeneric 05/2021
1	Leuprolide (Lupron)FDA LinkGeneric 05/2021
1	miriplatinIBA 04/2021
1	SuspensionsIBA 04/2021
1	Iodized OilIBA 04/2021
1	taxaneIBA 03/2021
1	Epirubicin (Ellence)FDA LinkGeneric 03/2021
1	TOPSIBA 11/2020
1	Estrogen Receptor alphaIBA 11/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2020
1	Cysteine (L-Cysteine)FDA Link 04/2020
1	eribulin FDA Link 03/2020
1	Lipocalin-2IBA 02/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	B7-H1 AntigenIBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	StathminIBA 11/2019
1	AnkyrinsIBA 07/2019

Therapy/Procedure

20	Therapeutics 01/2022 - 04/2006
8	Drug Therapy (Chemotherapy) 03/2021 - 05/2011
5	Neoadjuvant Therapy 08/2021 - 01/2014
5	Mammaplasty (Breast Reconstruction) 03/2021 - 09/2012
4	Mastectomy (Mammectomy) 03/2021 - 09/2012
4	Lymph Node Excision (Lymph Node Dissection) 04/2016 - 03/2010
3	Adjuvant Chemotherapy 03/2021 - 06/2016
2	Colectomy 06/2015 - 08/2011
1	Radiofrequency Ablation 04/2021
1	Tissue Expansion Devices (Tissue Expander) 07/2020
1	Time-to-Treatment 03/2020